345 related articles for article (PubMed ID: 19436671)
1. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.
George J; Struthers AD
Vasc Health Risk Manag; 2009; 5(1):265-72. PubMed ID: 19436671
[TBL] [Abstract][Full Text] [Related]
2. Allopurinol and endothelial function: A systematic review with meta-analysis of randomized controlled trials.
Alem MM
Cardiovasc Ther; 2018 Aug; 36(4):e12432. PubMed ID: 29673103
[TBL] [Abstract][Full Text] [Related]
3. The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review.
Britnell SR; Chillari KA; Brown JN
Curr Vasc Pharmacol; 2018; 16(6):583-588. PubMed ID: 28933307
[TBL] [Abstract][Full Text] [Related]
4. Allopurinol as a therapeutic option in cardiovascular disease.
Okafor ON; Farrington K; Gorog DA
Pharmacol Ther; 2017 Apr; 172():139-150. PubMed ID: 27916655
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol improves endothelial dysfunction in chronic heart failure.
Farquharson CA; Butler R; Hill A; Belch JJ; Struthers AD
Circulation; 2002 Jul; 106(2):221-6. PubMed ID: 12105162
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients.
Dogan A; Yarlioglues M; Kaya MG; Karadag Z; Dogan S; Ardic I; Dogdu O; Kilinc Y; Zencir C; Akpek M; Ozdogru I; Oguzhan A; Kalay N
Blood Press; 2011 Jun; 20(3):182-7. PubMed ID: 21133824
[TBL] [Abstract][Full Text] [Related]
7. Allopurinol and endothelial function in heart failure: future or fantasy?
Landmesser U; Drexler H
Circulation; 2002 Jul; 106(2):173-5. PubMed ID: 12105153
[No Abstract] [Full Text] [Related]
8. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.
Zhang Y; Chan MM; Andrews MC; Mori TA; Croft KD; McKenzie KU; Schyvens CG; Whitworth JA
Am J Hypertens; 2005 Jul; 18(7):910-6. PubMed ID: 16053986
[TBL] [Abstract][Full Text] [Related]
9. Effect of apple polyphenols on vascular oxidative stress and endothelium function: a translational study.
Cicero AFG; Caliceti C; Fogacci F; Giovannini M; Calabria D; Colletti A; Veronesi M; Roda A; Borghi C
Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28755406
[TBL] [Abstract][Full Text] [Related]
10. Xanthine oxidase inhibition protects against Western diet-induced aortic stiffness and impaired vasorelaxation in female mice.
Lastra G; Manrique C; Jia G; Aroor AR; Hayden MR; Barron BJ; Niles B; Padilla J; Sowers JR
Am J Physiol Regul Integr Comp Physiol; 2017 Aug; 313(2):R67-R77. PubMed ID: 28539355
[TBL] [Abstract][Full Text] [Related]
11. The role of urate and xanthine oxidase inhibitors in cardiovascular disease.
George J; Struthers AD
Cardiovasc Ther; 2008; 26(1):59-64. PubMed ID: 18466421
[TBL] [Abstract][Full Text] [Related]
12. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
Doehner W; Schoene N; Rauchhaus M; Leyva-Leon F; Pavitt DV; Reaveley DA; Schuler G; Coats AJ; Anker SD; Hambrecht R
Circulation; 2002 Jun; 105(22):2619-24. PubMed ID: 12045167
[TBL] [Abstract][Full Text] [Related]
13. Xanthine oxidase inhibition attenuates endothelial dysfunction caused by chronic intermittent hypoxia in rats.
Dopp JM; Philippi NR; Marcus NJ; Olson EB; Bird CE; Moran JJ; Mueller SW; Morgan BJ
Respiration; 2011; 82(5):458-67. PubMed ID: 21846958
[TBL] [Abstract][Full Text] [Related]
14. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.
Bove M; Cicero AF; Veronesi M; Borghi C
Vasc Health Risk Manag; 2017; 13():23-28. PubMed ID: 28223818
[TBL] [Abstract][Full Text] [Related]
15. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.
George J; Carr E; Davies J; Belch JJ; Struthers A
Circulation; 2006 Dec; 114(23):2508-16. PubMed ID: 17130343
[TBL] [Abstract][Full Text] [Related]
16. Xanthine oxidase inhibitors the unappreciated treatment for heart failure.
Ellestad MH
Cardiovasc Hematol Disord Drug Targets; 2007 Dec; 7(4):291-4. PubMed ID: 18220728
[TBL] [Abstract][Full Text] [Related]
17. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers.
Guthikonda S; Sinkey C; Barenz T; Haynes WG
Circulation; 2003 Jan; 107(3):416-21. PubMed ID: 12551865
[TBL] [Abstract][Full Text] [Related]
18. [Blood antioxidant capacity in gout].
Tsutsumi Z; Yamamoto T
Nihon Rinsho; 2003 Jan; 61 Suppl 1():465-9. PubMed ID: 12629767
[No Abstract] [Full Text] [Related]
19. Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials.
Xin W; Mi S; Lin Z
Cardiovasc Ther; 2016 Dec; 34(6):441-449. PubMed ID: 27542348
[TBL] [Abstract][Full Text] [Related]
20. The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.
Sakuma M; Toyoda S; Arikawa T; Koyabu Y; Kato T; Adachi T; Suwa H; Narita JI; Anraku K; Ishimura K; Yamauchi F; Sato Y; Inoue T;
Clin Exp Nephrol; 2018 Dec; 22(6):1379-1386. PubMed ID: 29916098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
